Immunoblot Criteria for Diagnosis of Lyme Disease: A Comparison of CDC Criteria to Alternative Interpretive Approaches

The current Centers for Disease Control and Prevention (CDC) interpretive criteria for serodiagnosis of Lyme disease (LD) involve a two-tiered approach, consisting of a first-tier EIA, IFA, or chemiluminescent assay, followed by confirmation of positive or equivocal results by either immunoblot or a...

Descripción completa

Detalles Bibliográficos
Autores principales: Porwancher, Richard, Levin, Andrew, Trevejo, Rosalie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674374/
https://www.ncbi.nlm.nih.gov/pubmed/38003747
http://dx.doi.org/10.3390/pathogens12111282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674374/
https://www.ncbi.nlm.nih.gov/pubmed/38003747
http://dx.doi.org/10.3390/pathogens12111282

Ejemplares similares